"Blood transfusion is a life-saving intervention that has an essential role in patient management within health care systems. All Member States of the World Health Organization (WHO) endorsed World Health Assembly resolutions WHA28.72 (1) in 1975 and WHA58.13 (2) in 2005. These commit them to the provision of adequate supplies of safe blood and blood products that are accessible to all patients who require transfusion either to save their lives or promote their continuing or improving health." --Preface.

During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was doneâ€"and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatmentâ€"Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referralâ€"including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated bloodâ€"analyzing decisions by federal agencies and the private sector. Risk communicationâ€"examining whether infections could have been averted by better communication of the risks.

The WHO guidelines on assessing donor suitability for blood donation have been developed to assist blood transfusion services in countries that are establishing or strengthening national systems for the selection of blood donors. They are designed for use by policy makers in national blood programmes in ministries of health, national advisory bodies such as national blood commissions or councils, and blood transfusion services.

This volume discusses the current state of the nation's blood supply--including studies of blood availability, ways of enhancing blood collection and distribution, frozen red cell technology, logistical concerns in prepositioning frozen blood, extended liquid storage of red cells, and blood substitutes.

This volume examines regulatory and policymaking procedures in blood banking, regulatory enforcement and compliance, innovations and alternatives in regulation, congressional oversight and regulatory initiatives, and investment in regulatory quality.

"The most important book to read about the AI boom" (Wired): The "gripping" (New Yorker) true story of the first time machines came for human jobs—and how the Luddite uprising explains the power, threat, and toll of big tech and AI today Named one of the best books of the year by The New Yorker, Wired, and the Financial Times • A Next Big Idea Book Club "Must-Read" The most urgent story in modern tech begins not in Silicon Valley but two hundred years ago in rural England, when workers known as the Luddites rose up rather than starve at the hands of factory owners who were using automated machines to erase their livelihoods. The Luddites organized guerrilla raids to smash those machines—on punishment of death—and won the support of Lord Byron, enraged the Prince Regent, and inspired the birth of science fiction. This all-but-forgotten class struggle brought nineteenth-century England to its knees. Today, technology imperils millions of jobs, robots are crowding factory floors, and artificial intelligence will soon pervade every aspect of our economy. How will this change the way we live? And what can we do about it? The answers lie in Blood in the Machine. Brian Merchant intertwines a lucid examination of our current age with the story of the Luddites, showing how automation changed our world—and is shaping our future.

Using an easy-to-understand writing style, this text integrates immunohematology theory and application to provide you with the knowledge and skills you need to be successful in blood banking. Problem-solving exercises and case studies help you develop a solid understanding of all areas of blood banking. Learning objectives begin each chapter. Illustrated blood group boxes throughout chapter 6, Other Blood Group Systems, give the ISBT symbol, number, and the clinical significance of the antibodies at a glance. Margin notes and definitions in each chapter highlight important material and offer additional explanations. Chapter summaries recap the most important points of the chapter. Study questions at the end of each chapter provide an opportunity for review. Critical thinking exercises with case studies help you apply what you have learned in the chapter. UPDATED! Information and photos on automation include equipment actually used in the lab. Flow charts showing antibody detection and identification help you detect and identify antibodies. Advanced topics on Transplantation and Cellular Therapy, the HLA System, Molecular Techniques and Applications, Automation, Electronic Crossmatching, and Therapeutic Apheresis make the text relevant for 4-year MLS programs.

Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood outlines the fundamental design concepts and emerging applications of nanotechnology in hematology, blood transfusion and artificial blood. This book is an important reference source for materials scientists, engineers and biomedical scientists who are looking to increase their understanding of how nanotechnology can lead to more efficient blood treatments. Sections focus on how nanotechnology could offer new routes to address challenging and pressing issues facing rare blood diseases and disorders and how nanomaterials can be used as artificial cell-like systems (compartmentalized biomimetic nanocontainers), which are especially useful in drug delivery. For artificial blood, the nanotechnological approach can fabricate artificial red blood cells, platelet substitutes, and white blood cell substitutes with their inherent enzyme and other supportive systems. In addition, nanomaterials can promote blood vessel growth and reserve red blood cells at a positive temperature. - Provides information on how nanotechnology can be used to create more efficient solutions for blood transfusions and hematology treatments - Explores the major nanomaterial types that are used for these treatments - Assesses the major challenges of using nanomaterials hematology